Vertex Pharmaceuticals Inc
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
Health
Rachel Carter
Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The crippling episodes of pain from ...
US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder
Business
Jessica Roberts
The headquarters of US biopharmaceutical company Vertex Pharmaceuticals in Boston, Massachusets, on November 4, 2023. Joseph Prezioso | Afp | Getty Images ...
First CRISPR gene-editing treatment approved in U.S.
Health
Rachel Carter
The U.S. Food and Drug Administration has approved Casgevy, the first gene-editing treatment to be marketed in the country. Casgevy uses Nobel ...
U.S. poised to approve breakthrough treatment
Health
Rachel Carter
At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his ...
